HEALTHCARE ANALYTICS
PRNewswire | June 01, 2023
XRHealth, a Boston-based developer and operator of virtual treatment rooms, announces today their adoption of Snapdragon Spaces™ XR Developer Platform for the Lenovo ThinkReality VRX. The integration will enable XRHealth developers to create immersive experiences in AR/VR/MR for the healthcare industry. Lenovo's ThinkReality VRX is one of the first headsets launched with Snapdragon Spaces to empower developers to expand the XR ecosystem. Lenovo ThinkReality VRX will now be preloaded with XRHealth therapeutic solutions.
"Snapdragon Spaces is created to provide application developers the software tools to build immersive XR solutions and innovate using immersive technology," said Martin Herdina, Senior Director, Product Management, XR. "XR Health brings impressive technology to the table in their virtual healthcare and therapy solution, and Qualcomm Technologies, Inc. is excited to work with them as part of its rapidly growing XR enterprise ecosystem."
Lenovo and Qualcomm Technologies have long worked together to expand the enterprise metaverse and virtual workspaces. With XRHealth's adoption of Snapdragon Spaces, developers will be able to create immersive VR healthcare experiences on devices powered by Snapdragon®, offering developers the option to develop VR, AR, or MR experiences on the leading headsets for training and collaboration in 3D. Lenovo's ThinkReality VRX headset that will support both Snapdragon Spaces and XRHealth will be available in Q3 of 2023.
"We are excited to integrate our solution on Snapdragon Spaces and Lenovo ThinkReality VRX to enable developers to build innovative experiences that will revolutionize therapeutic care," says Eran Orr, CEO of XRHealth. "We are honored to join Qualcomm Technologies' first cohort of companies developing on VRX using Snapdragon Spaces technology."
This announcement comes at the heels of XRHealth announcing a merger with Amelia Virtual Care which has created a XR therapeutic powerhouse, addressing both physical and mental health issues.
XRHealth will demonstrate the headset at AWE in Santa Clara, CA during May 31-June 2 at Lenovo's booth #219 and Qualcomm's booth #205 at Hall A.
About XRHealth
XRHealth operates state-of-the-art therapeutic care Virtual Rooms, utilizing proprietary FDA and CE-registered medical Extended Reality (XR) technology (virtual and augmented reality). XRHealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. XRHealth works with several world-renowned U.S. healthcare providers, hospitals, and rehabilitation centers. Founded in 2016, XRHealth is headquartered in Boston,
Read More
DIGITAL HEALTHCARE, MEDICAL DEVICES
Businesswire | June 06, 2023
Carbon Health announced the launch of hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers. Carbon Health’s EHR (electronic health records) platform is the first to deploy native AI-assisted charting at scale.
With the patent-pending technology, Carbon Health has developed a way for providers to generate comprehensive and accurate medical notes more efficiently with the press of a record button. Built directly into the Carbon Health EHR and designed to fit seamlessly into a provider’s existing workflow, the integration saves time and enhances the patient-doctor connection. Without a screen between them and their patients, doctors can focus more time on care and less on typing.
“The rapid development and deployment of hands-free charting advances Carbon Health's AI-enabled EHR and shows how quickly AI can have a real-world impact on care delivery,” said Carbon Health CEO Eren Bali. “Our vertically integrated model of providers, clinics, and software makes our system uniquely positioned to leverage AI technologies like GPT-4.”
Early data shows immediate benefits for providers
Efficiency: On average, the system generates a complete medical chart in less than 4 minutes compared to 16 minutes for a manual chart
Accuracy: 88% of the AI-generated text is accepted by the provider without edits
Completeness: Charts are 2.5x more detailed than manual entry
Hands-free charting starts with patient consent at the beginning of a visit. Once consent is obtained, with a simple press of a record button in the Carbon Health EHR, audio is captured and transcribed using AWS Transcribe Medical. The transcript is then combined with other patient information such as demographics, vitals, lab results, and manually added notes from the provider. Within minutes, a visit summary is auto-generated in the patient’s chart, allowing a provider to review, adjust, and finalize it as the medical decision-maker, all within the EHR.
“It's tough to imagine my shifts without this technology,” said Dr. Caesar Djavaherian, Carbon Health Chief Clinical Innovation Officer. “Carbon Health’s hands-free charting feature provides a level of detail and accuracy that we could never achieve with manual notes. I'm never going back.”
In a pilot test, a Carbon Health clinic in San Francisco, CA, saw a 30% increase in patients compared to typical visit volume, without added stress on the team, thanks to the use of hands-free charting on the backend. This increase in throughput without an increase in administrative burden shows what’s possible when AI is seamlessly built into a team's day-to-day workflows.
“It’s about eye contact over iPads,” said Bali. “For too long, providers have had to choose between connecting with their patients and taking notes. That will no longer be the case at Carbon Health clinics. We’re unlocking the ability for clinics to meet the needs of the community without trade-offs like burnout or exhaustion.”
About Carbon Health
Carbon Health is a modern healthcare company that offers in-person and virtual care for easier everyday health. By combining custom technology with expert care, Carbon Health enables patients to establish a direct relationship with an integrated team, monitor and manage their health on the go, and access care when and where they need it.
Building on the success of its nationwide urgent care network, Carbon Health treats the full spectrum of needs – from acute issues to chronic conditions, as well as ongoing physical and mental health. The company is also expanding into value-based care through work with employers, health plans, health systems, and other ecosystem partners.
Read More
HEALTHCARE ANALYTICS
Businesswire | May 31, 2023
HeartBeam, Inc. a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. HeartBeam acquired the assets of LIVMOR earlier this year.
Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team's expertise and patented technology in the assessment and monitoring of cardiac symptoms.
“The goal of this partnership is to bring standard of care for cardiac diagnostic capabilities to patients by utilizing cutting edge technologies of both Samsung and HeartBeam,” said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder. “Our newly acquired state of the art, FDA cleared, Samsung watch-based arrhythmia detection tool, once integrated with the HeartBeam AIMIGo™ telehealth platform, presents a unique opportunity to extend our product capabilities well beyond what is currently available for cardiac patients outside of a medical setting.”
Kevin Jones, Senior Director, Federal Healthcare, Samsung Electronics America, added, “The strategic collaboration between Samsung and LIVMOR was very successful, resulting in an FDA cleared solution for Atrial Fibrillation detection centered around the Samsung Galaxy watch and tablet running Samsung's defense-grade cyber-security system, Knox. We are excited that LIVMOR is now part of HeartBeam and look forward to continuing our successful collaboration. The potential of combining LIVMOR’s technology and the HeartBeam AIMIGo system holds significant promise to address major cardiac conditions for our veterans.”
Founded in 2016, LIVMOR developed the Halo™ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The Halo system provides continuous monitoring of pulse rhythms for the detection of AF on-demand during the day and automatically overnight. Under the previous SAA, LIVMOR and Samsung developed a physician-prescribed and fully integrated patient care platform that provides extended monitoring of patient cardiovascular health in virtually any setting, using medical grade equipment. LIVMOR’s technology was commercially deployed within the VA Healthcare System in Dallas, Texas.
“Thanks to our cooperation with LIVMOR and Samsung, we are able to treat some of the nation’s most at-risk patients as safely and effectively from the comfort of their homes as we would if they were sitting in an exam room,” said Dr. Jerrold Grodin, Department of Veterans Affairs, North Texas. “We’ve seen an increase in early adoption from patients when their physicians are also early adopters.”
Among the available opportunities is a potential collaboration with the Department of Veterans Affairs through its Accelerating VA Innovation and Learning (AVAIL) program. In September, the VA announced that 17 companies had won spots in a potential five-year, $650 million healthcare technology research and development program. Participants provide subject-matter expertise to help the agency design, build and test novel platforms, services and care models that could be scaled into clinical production to support the Veterans Health Administration.
One of the AVAIL program's awardees is Longview International Technology Solutions (LTS), a systems integration company. LIVMOR and Samsung have been designated as official collaborators with LTS for the AVAIL project. With the Company’s anticipated participation in the AVAIL project, HeartBeam could share its expertise in the assessment and monitoring of cardiac symptoms as it collaborates with Samsung to innovate and develop solutions for the VA, the largest integrated healthcare system in the U.S.
"Veterans reported a rate of heart attacks more than twice that of non-veterans in one study," Dr. Vajdic added. "This shows that coronary artery disease is a significant problem for veterans, making improvements in heart attack detection at the VA particularly critical."
About HeartBeam, Inc.
HeartBeam, Inc. is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to assess their cardiac symptoms quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies.
Read More